DOI: 10.1055/s-00000030

Der Klinikarzt

References

Pignata S, Lorusso D, Joly F. et al.
Chemotherapy plus or minus bevacizumab for platinum-sensitive ovarian cancer patients recurring after a bevacizumab containing first line treatment: The randomized phase 3 trial MITO16B-MaNGO OV2B-ENGOT OV17.

J Clin Oncol 2018;
36 (15_suppl) 5506-5506

Download Bibliographical Data

Search in:
Access: